A groundbreaking multi-institutional collaboration, spearheaded by researchers at Michigan State University (MI, USA), has unveiled a novel machine-learning-based drug discovery…
Read More
Eli Lilly Ascends to Pharmaceutical Revenue Zenith with Oral GLP-1 Approval, Yet Wall Street Remains Unconvinced
Indianapolis, IN – Eli Lilly and Company, a venerable pharmaceutical giant, has officially seized the top position in global pharmaceutical…
Read More
Immersive Dreams Enhance Perceived Sleep Depth and Act as Guardians of Restful Sleep
The scientific community has long grappled with the discrepancy between objective sleep metrics and the subjective experience of rest. While…
Read More
HNSCC market is expected to reach to $4.5bn across 8MM by 2034 – Pharmaceutical Technology
The global market for head and neck squamous cell carcinoma (HNSCC) therapeutics is poised for significant expansion, with projections indicating…
Read More
New fossils from the Ediacaran Period show that some animal groups are older than we thought
A remarkable discovery of exceptionally preserved fossils from China’s Ediacaran Period is rewriting our understanding of early animal evolution. Unearthed…
Read More
"Just in Time" World Modeling Supports Human Planning and Reasoning
A recently published paper, "Just in Time" World Modeling Supports Human Planning and Reasoning, accessible via arXiv, introduces a novel…
Read More
Genome’s Early Architectural Masterpiece Revealed: A Paradigm Shift in Developmental Biology
For decades, the prevailing scientific consensus painted a picture of the genome within a newly fertilized egg as a chaotic,…
Read More
TWiV 1287: Ancient herpesviruses and modern dementia
Virologists Uncover Deep History of Human Herpesviruses and Explore Shingles Vaccine’s Impact on Dementia In a wide-ranging discussion broadcast on…
Read More
The Gut-Brain Axis: Unveiling the Microbiome’s Profound Influence on Neurological Health and Disease
The intricate connection between the far-flung organs of the gastrointestinal tract and the central nervous system, commonly known as the…
Read More
Novo Nordisk’s triple agonist delivers up to 19.7% average weight loss in Phase 2 trial
Novo Nordisk, a global leader in diabetes and obesity care, recently announced compelling Phase 2 trial results for its investigational…
Read More
